Literature DB >> 9854125

Making medicines safer--the need for an independent drug safety board.

A J Wood1, C M Stein, R Woosley.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9854125     DOI： 10.1056/NEJM199812173392512

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

1.  Underreporting of adverse drug reactions: attitudes of Irish doctors.

Authors:  D Williams; J Feely
Journal:  Ir J Med Sci       Date:  1999 Oct-Dec       Impact factor: 1.568

2.  Enhancing public confidence in vaccines through independent oversight of postlicensure vaccine safety.

Authors:  Daniel A Salmon; Lawrence H Moulton; Neal A Halsey
Journal:  Am J Public Health       Date:  2004-06       Impact factor: 9.308

3.  Discussion point: should governments buy drug patents?

Authors:  Juan del Llano
Journal:  Eur J Health Econ       Date:  2007-06

4.  Preemption, tort reform, and pharmaceutical claims: Part two: Has the Food and Drug Administration shown it is solely responsible for the protection of patients? Can it do so? Will it do so?

Authors:  Russell G Thornton
Journal:  Proc (Bayl Univ Med Cent)       Date:  2008-01

5.  Randomized controlled trials and assessment of drug safety.

Authors:  David W J Clark; David M Coulter; Frank M C Besag
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

6.  Adverse event detection in drug development: recommendations and obligations beyond phase 3.

Authors:  Jesse A Berlin; Susan C Glasser; Susan S Ellenberg
Journal:  Am J Public Health       Date:  2008-06-12       Impact factor: 9.308

7.  A call to incorporate systems theory and human factors into the existing investigation of harm in clinical research involving healthcare products.

Authors:  Brian D Edwards; Bernard Bégaud; Esther Daemen; Ioannis Dokas; Jonathan M Fishbein; Howard E Greenberg; Alan Hochberg; Hervé Le Louet; Jytte Lyngvig; Nataliya Mogles; Kathryn Owen; Christine Prendergast; Martin Rejzek; Sophia Trantza; David J Webb; Matthew Whalen; Simon Whiteley
Journal:  Br J Clin Pharmacol       Date:  2017-07-19       Impact factor: 4.335

8.  Adverse reactions related to drugs for headache treatment: clinical impact.

Authors:  Anna Ferrari; Alessandra Ottani; Alfio Bertolini; Arrigo Francesco Giuseppe Cicero; Ciro Pio Rosario Coccia; Sheila Leone; Emilio Sternieri
Journal:  Eur J Clin Pharmacol       Date:  2005-01-19       Impact factor: 2.953

9.  Pioglitazone initiation and subsequent hospitalization for congestive heart failure.

Authors:  A J Karter; A T Ahmed; J Liu; H H Moffet; M M Parker
Journal:  Diabet Med       Date:  2005-08       Impact factor: 4.359

10.  Acute kidney injury and bisphosphonate use in cancer: a report from the research on adverse drug events and reports (RADAR) project.

Authors:  Beatrice J Edwards; Sarah Usmani; Dennis W Raisch; June M McKoy; Athena T Samaras; Steven M Belknap; Steven M Trifilio; Allison Hahr; Andrew D Bunta; Ali Abu-Alfa; Craig B Langman; Steve T Rosen; Dennis P West
Journal:  J Oncol Pract       Date:  2013-03       Impact factor: 3.840
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.